YS Biopharma Co. Ltd.

NASDAQ: YS · Real-Time Price · USD
1.02
0.09 (9.68%)
At close: May 24, 2024, 10:00 PM

YS Biopharma Cash Flow Statement

Financials in CNY. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
-145.48M -106M -191.83M
Depreciation & Amortization
36.69M 31.15M 27.91M
Stock-Based Compensation
3.5M 7.76M 76.76M
Other Working Capital
41.02M 49.23M 107.2M
Other Non-Cash Items
14.43M 13.54M 9.78M
Deferred Income Tax
1.13M 4.94M 17.45M
Change in Working Capital
-92.75M -124.94M -186.68M
Operating Cash Flow
-182.47M -173.55M -246.61M
Capital Expenditures
-57.05M -298.93M -104.88M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
68K 8K 644.84K
Investing Cash Flow
-56.98M -298.92M -104.24M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
317.45M 364.56M 739.26M
Financial Cash Flow
317.45M 364.56M 739.26M
Net Cash Flow
99.3M -119.39M 388.41M
Free Cash Flow
-239.52M -472.48M -351.49M